Overall, the results of this study demonstrated that CSP could attenuate hepatic steatosis and decrease liver inflammation via the TNFα/TNFR1 signaling pathway in mice with HFHFD plus CIS. The gene discussed is TNFRSF1A; the disease is in situ carcinoma.